Prati
Javad Garousi (orcid.org/0000-0002-7224-6304)
Javad Garousi (orcid.org/0000-0002-7224-6304)
Potvrđena adresa e-pošte na igp.uu.se
Naslov
Citirano
Citirano
Godina
ADAPT, a novel scaffold protein-based probe for radionuclide imaging of molecular targets that are expressed in disseminated cancers
J Garousi, S Lindbo, J Nilvebrant, M Åstrand, J Buijs, M Sandström, ...
Cancer research 75 (20), 4364-4371, 2015
812015
Tailored doxorubicin‐H yaluronan conjugate as a potent anticancer glyco‐D rug: an alternative to prodrug approach
OP Oommen, J Garousi, M Sloff, OP Varghese
Macromolecular bioscience 14 (3), 327-333, 2014
792014
Phase I Study of 99mTc-ADAPT6, a Scaffold Protein–Based Probe for Visualization of HER2 Expression in Breast Cancer
O Bragina, E von Witting, J Garousi, R Zelchan, M Sandström, A Orlova, ...
Journal of nuclear medicine 62 (4), 493-499, 2021
762021
Optimal composition and position of histidine-containing tags improves biodistribution of 99mTc-labeled DARPin G3
A Vorobyeva, A Schulga, E Konovalova, R Güler, J Löfblom, M Sandström, ...
Scientific Reports 9 (1), 9405, 2019
622019
PET imaging of epidermal growth factor receptor expression in tumours using 89Zr-labelled ZEGFR: 2377 affibody molecules
J Garousi, KG Andersson, B Mitran, ML Pichl, S Ståhl, A Orlova, J Löfblom, ...
International journal of oncology 48 (4), 1325-1332, 2016
602016
Influence of histidine-containing tags on the biodistribution of ADAPT scaffold proteins
S Lindbo, J Garousi, M Åstrand, H Honarvar, A Orlova, S Hober, ...
Bioconjugate chemistry 27 (3), 716-726, 2016
552016
Comparative evaluation of two DARPin variants: effect of affinity, size, and label on tumor targeting properties
S Deyev, A Vorobyeva, A Schulga, G Proshkina, R Guler, J Lofblom, ...
Molecular pharmaceutics 16 (3), 995-1008, 2019
502019
Imaging using radiolabelled targeted proteins: Radioimmunodetection and beyond
J Garousi, A Orlova, FY Frejd, V Tolmachev
EJNMMI radiopharmacy and chemistry 5, 1-26, 2020
492020
Comparative evaluation of affibody molecules for radionuclide imaging of in vivo expression of carbonic anhydrase IX
J Garousi, H Honarvar, KG Andersson, B Mitran, A Orlova, J Buijs, ...
Molecular pharmaceutics 13 (11), 3676-3687, 2016
442016
Radionuclide tumor targeting using ADAPT scaffold proteins: aspects of label positioning and residualizing properties of the label
S Lindbo, J Garousi, B Mitran, M Altai, J Buijs, A Orlova, S Hober, ...
Journal of Nuclear Medicine 59 (1), 93-99, 2018
422018
Imaging of CAIX-expressing xenografts in vivo using 99mTc-HEHEHE-ZCAIX: 1 affibody molecule
H HONARvAR, J Garousi, E Gunneriusson, I HöIDéN-GUTHENbERG, ...
International journal of oncology 46 (2), 513-520, 2015
372015
Cyclic versus Noncyclic Chelating Scaffold for 89Zr-Labeled ZEGFR:2377 Affibody Bioconjugates Targeting Epidermal Growth Factor Receptor Overexpression
D Summer, J Garousi, M Oroujeni, B Mitran, KG Andersson, A Vorobyeva, ...
Molecular pharmaceutics 15 (1), 175-185, 2018
362018
Characterization of pure and antimony doped SnO2 thin films prepared by the sol-gel technique
AAJ NOVINROUZ, P Sarabadani, J Garousi
IRANIAN JOURNAL OF CHEMISTRY AND CHEMICAL ENGINEERING (IJCCE) 25 (2), 32-38, 2006
362006
The use of radiocobalt as a label improves imaging of EGFR using DOTA-conjugated Affibody molecule
J Garousi, KG Andersson, JH Dam, BB Olsen, B Mitran, A Orlova, J Buijs, ...
Scientific Reports 7 (1), 5961, 2017
352017
Feasibility of imaging of epidermal growth factor receptor expression with ZEGFR: 2377 affibody molecule labeled with 99mTc using a peptide-based cysteine-containing chelator
KG Andersson, M Oroujeni, J Garousi, B Mitran, S Ståhl, A Orlova, ...
International journal of oncology 49 (6), 2285-2293, 2016
332016
Comparative evaluation of dimeric and monomeric forms of ADAPT scaffold protein for targeting of HER2-expressing tumours
J Garousi, S Lindbo, J Borin, E von Witting, A Vorobyeva, M Oroujeni, ...
European journal of pharmaceutics and biopharmaceutics 134, 37-48, 2019
322019
Comparison of tumor‑targeting properties of directly and indirectly radioiodinated designed ankyrin repeat protein (DARPin) G3 variants for molecular imaging of HER2
A Vorobyeva, A Sсhulga, E Konovalova, R Güler, B Mitran, J Garousi, ...
International journal of oncology 54 (4), 1209-1220, 2019
302019
Selection of the optimal macrocyclic chelators for labeling with 111In and 68Ga improves contrast of HER2 imaging using engineered scaffold protein ADAPT6
E von Witting, J Garousi, S Lindbo, A Vorobyeva, M Altai, M Oroujeni, ...
European journal of pharmaceutics and biopharmaceutics 140, 109-120, 2019
282019
Preclinical Evaluation of [68Ga]Ga-DFO-ZEGFR:2377: A Promising Affibody-Based Probe for Noninvasive PET Imaging of EGFR Expression in Tumors
M Oroujeni, J Garousi, KG Andersson, J Löfblom, B Mitran, A Orlova, ...
Cells 7 (9), 141, 2018
282018
Effect of a radiolabel biochemical nature on tumor-targeting properties of EpCAM-binding engineered scaffold protein DARPin Ec1
SM Deyev, A Vorobyeva, A Schulga, A Abouzayed, T Günther, J Garousi, ...
International journal of biological macromolecules 145, 216-225, 2020
272020
Sustav trenutno ne može provesti ovu radnju. Pokušajte ponovo kasnije.
Članci 1–20